Corbus Pharmaceuticals' GAAP loss for 2021 was $45.64 million, down 2.4 times from $111.269 million in the previous year. Revenue decreased 4.5 times to $0.882 million from $3.937 million a year earlier.
Corbus Pharmaceuticals' GAAP loss for 2021 was $45.64 million, down 2.4 times from $111.269 million in the previous year. Revenue decreased 4.5 times to $0.882 million from $3.937 million a year earlier. 
ir.corbuspharma.com
English (US) 